Recombinant yeast in drug metabolism
- 5 October 1993
- journal article
- review article
- Published by Elsevier in Toxicology
- Vol. 82 (1-3), 39-52
- https://doi.org/10.1016/0300-483x(93)90058-z
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5Gene, 1993
- Optimization of yeast‐expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH‐cytochrome P450 reductase and cytochrome b5European Journal of Biochemistry, 1992
- Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9Biochemical and Biophysical Research Communications, 1991
- Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiaeBiochemistry, 1990
- Expression of human liver cytochrome P450 IIIA4 in yeastEuropean Journal of Biochemistry, 1990
- Constitutive and inducible expression of human cytochrome P450IA1 in yeast Saccharomyces cerevisiae: An alternative enzyme source for in vitro studiesBiochemical and Biophysical Research Communications, 1990
- Maximizing the expression of mammalian cytochrome P-450 monooxygenase activities in yeast cellsBiochimie, 1990
- Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiaeBiochemistry, 1989
- Human P450PCN1: Sequence, Chromosome Localization, and Direct Evidence through cDNA Expression That P450PCN1 Is Nifedipine OxidaseDNA, 1988
- Pharmacokinetic Interactions of the Macrolide AntibioticsClinical Pharmacokinetics, 1985